To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Tripos Announces Chemistry Collaboration with Abbott
Tripos, Inc. has announced a chemistry collaboration with Abbott to design, synthesize and purify high-quality, novel, drug-like compounds to expand Abbott’s compound file collection. Tripos and Abbott will collaborate in library design, analysis and synthesis.
"The success of high-throughput technologies in pharmaceutical research is highly dependent on the close coupling of informatics and experimental science," said Dr. John P. McAlister, president and chief executive officer of Tripos.
"With its fully integrated, information-driven chemistry operations, including cutting-edge ChemCore™ and ChemSpace® technologies, Tripos is positioned to add value to the chemical libraries delivered to Abbott."
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
